# US 2006/0052353 A1 · Topical dermatological formulations and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0052353 A1
- Document ID: US20060052353A1
- Status: Published application
- Kind: A1
- Application number: 10/933,976
- Filed: 2004-09-03
- Published: 2006-03-09
- Earliest claimed: 2004-09-03
- Assignees: Therapeutics, Inc.
- Inventors: Keith Johnson
- Web page: https://patentgrep.com/patent/US20060052353A1

## CPC

- A61K 31/573: substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A topical formulation of an androstane steroid compound of improved solubility in combinations of the solvents propylene glycol and propylene carbonate.

## Claims

### Claim 1

A composition for topical administration comprising an androstane steroid compound in a formulation having both propylene glycol and propylene carbonate solvents.

### Claim 2 (depends on 1)

A composition according to claim 1 wherein the androstane steroid is a compound of the formula:
where R1 is selected from the group consisting of a fluoro-, chloro-, bromo-methyl group or a 2′-fluoromethyl group; R2 is a group COR6 where R6 is selected from the group consisting of a C1-3 alkyl group or OR2 and R3 together form a 16α,17α-isopropylidenedioxy group; R3 is selected from the group consisting of a hydrogen atom, a methyl group and a methylene group; R4 is selected from the group consisting of a hydrogen, chlorine and fluorine atom; and R5 is selected from the group consisting of a hydrogen and a fluorine atom, and the symbol -- represents a single or double bond.

### Claim 3 (depends on 1)

A composition according to claim 1 wherein the androstane steroid compound is fluticasone propionate.

### Claim 4 (depends on 1)

A composition according to claim 1 wherein the weight ratio of ratio of propylene carbonate to propylene glycol in the composition is from about 99:5 to about 5:99.

### Claim 5 (depends on 1)

A composition according to claim 1 wherein the weight ratio of ratio of propylene carbonate to propylene glycol in the composition is from about 88:12 to about 45:55.

### Claim 6 (depends on 1)

A composition according to claim 1 wherein the weight ratio of ratio of propylene carbonate to propylene glycol in the composition is about 88:12.

### Claim 7 (depends on 3)

A composition according to claim 3 wherein the weight ratio of ratio of propylene carbonate to propylene glycol in the composition is from about 99:5 to about 5:99.

### Claim 8 (depends on 3)

A composition according to claim 3 wherein the weight ratio of ratio of propylene carbonate to propylene glycol in the composition is from about 88:12 to about 45:55.

### Claim 9 (depends on 3)

A composition according to claim 3 wherein the weight ratio of ratio of propylene carbonate to propylene glycol in the composition is about 88:12.

### Claim 10 (depends on 1)

A composition according to claim 1 wherein the composition is an ointment.

### Claim 11 (depends on 1)

A composition according to claim 1 wherein the composition is a cream or lotion.

### Claim 12 (depends on 3)

A composition according to claim 3 wherein the composition is an ointment.

### Claim 13 (depends on 3)

A composition according to claim 3 wherein the composition is a cream or lotion.

### Claim 14 (depends on 1)

A composition according to claim 1 which is an ointment and comprising on a weight/weight basis
Component
Amount (% w/w)
Androstane steroid
0.005 to 0.1
Propylene carbonate1
2.5 to 7.5
Propylene glycol
2.5 to 7.5
Surfactant
0.5 to 1.0
Wax
20 to 30
Emollient
0.0 to 10
Penetration enhancer
0.0 to 5.0
Mineral oil
Q.s.
and the total of the propylene glycol and propylene carbonate components is about 10% or less.

### Claim 15 (depends on 14)

The composition according to claim 14 wherein the androstane steroid is fluticasone propionate.

### Claim 16 (depends on 1)

The composition according to claim 1 which is a cream or lotion and comprising on a weight/weight basis
Component
Amount (% w/w)
Androstane steroid
0.05 to 0.20
Propylene carbonate
2.5 to 10
Propylene glycol
2.5 to 10
Surfactant
1.0 to 10
Stiffening agent(s)
0.1 to 14
Waxes
5.0 to 20
Emollient(s)
2.0 to 40
Penetration enhancer
0.0 to 5.0
Mineral oil
0.0 to 5.0
Preservatives
0.3 to 0.6
Polymer
0.0 to 5.0%
Base
0.0 to 5.0%
Water (buffer)
Q.s.
and the total of the propylene glycol and propylene carbonate components is about 35% or less.

### Claim 17 (depends on 16)

A composition according to claim 16 wherein the androstane steroid comprises fluticasone propionate.

### Claim 18 (depends on 1)

A composition according to claim 1 additionally comprising one or more of the following components surfactant(s), stiffening or thickening agent(s), wax(es), occlusive agent(s), emollient(s), penetration enhancer(s), preservative(s), base(s), and water or buffer,

### Claim 19 (depends on 18)

A composition according to claim 18 wherein the androstane steroid is fluticasone propionate.

### Claim 20 (depends on 1)

A composition according to claim 1 comprising an ointment having on a w/w % basis
Component
Approximate %
Fluticasone
0.05
propionate
Microcrystalline
30
Wax
Sorbitan
1.5
sesquioleate
Glycerol
1.5
monostearate
Oleic acid
2.5
Butylated
0.05
hydroxytoluene
Propylene
0.825
glycol
Propylene
2.475
carbonate
Mineral oil
61.1
and the total of the propylene glycol and propylene carbonate components is about 10% or less.

### Claim 21 (depends on 1)

A composition according to claim 1 comprising an ointment having on a weight/weight basis
Component
Approximate w/w %
Fluticasone
0.02
propionate
Microcrystalline
30
Wax
Sorbitan
2
sesquioleate
Glycerol
1.5
monostearate
Oleic acid
1
Butylated
0.05
hydroxytoluene
Propylene
3.15
glycol
Propylene
1.05
carbonate
Mineral oil
61.23

### Claim 22 (depends on 1)

A composition according to claim 1 comprising an ointment having on a wt/wt basis
Component
Approximate w/w %
Fluticasone
0.075
propionate
Microcrystalline
30
Wax
Sorbitan
3
sesquioleate
Glycerol
1.5
monostearate
Oleic acid
2.5
Butylated
0.05
hydroxytoluene
Propylene
1.25
glycol
Propylene
3.75
carbonate
Mineral oil
57.875

### Claim 23

A method for treating a skin condition, the process comprising topically applying to the skin a composition comprising an androstane steroid compound in a formulation having both propylene glycol and propylene carbonate solvents.

### Claim 24 (depends on 23)

A method according to claim 23 wherein the androstane steroid is a compound of the formula:
where R1 is selected from the group consisting of a fluoro-, chloro-, bromo-methyl group or a 2′-fluoromethyl group; R2 is a group COR6 where R6 is selected from the group consisting of a C1-3 alkyl group or OR2 and R3 together form a 16α,17α-isopropylidenedioxy group; R3 is selected from the group consisting of a hydrogen atom, a methyl group and a methylene group; R4 is selected from the group consisting of a hydrogen, chlorine and fluorine atom; and R5 is selected from the group consisting of a hydrogen and a fluorine atom, and the symbol -- represents a single or double bond.

### Claim 25 (depends on 24)

A method according to claim 24 wherein the androstane steroid is fluticasone propionate.

### Claim 26 (depends on 24)

A method according to claim 24 wherein composition is an ointment comprising on a weight/weight basis
Component
Approximate w/w %
Androstane steroid
0.005 to 0.1
Propylene carbonate1
2.5 to 7.5
Propylene glycol
2.5 to 7.5
Surfactant
0.5 to 1.0
Wax
20 to 30
Emollient
0.0 to 10
Penetration enhancer
0.0 to 5.0
Mineral oil
Q.s.

### Claim 27 (depends on 26)

A method according to claim 26 wherein the androstane steroid is fluticasone propionate

### Claim 28 (depends on 24)

A method according to claim 24 wherein the composition is a cream or lotion and comprising on a weight/weight basis
Component
Approximate w/w %
Androstane steroid
0.05 to 0.15
Propylene carbonate
2.5 to 15
Propylene glycol
2.5 to 20
Surfactant
1.0 to 10
Stiffening agent(s)
0.1 to 10
Waxes
5.0 to 20
Emollient(s)
2.0 to 40
Penetration enhancer
0.0 to 5.0
Mineral oil
0.0 to 5.0
Preservatives
0.3 to 0.6
Polymer
0.0 to 5.0%
Base
0.0 to 5.0%
Water (buffer)
Q.s.
and the total of the propylene glycol and propylene carbonate components is about 35% or less.

### Claim 29 (depends on 28)

A method according to claim 28 wherein the androstane steroid is fluticasone propionate.

### Claim 30 (depends on 24)

A method according to claim 24 wherein the skin condition is selected from the group consisting of corticosteroid-responsive dermatoses, atopic dermatitis, inflammation, eczema, erythema, papulation, scaling erosion, oozing, crusting, pruritus, impetigo, epidermolysis bullosa, psoriasis, erythema, hidradenitis, suppurative warts, diaper rash, jock itch, and combinations of these conditions.
